ClinicalTrialsFinder

Extensive Disease Small Cell Lung Cancer Clinical Trials in Changsha, Hunan

1 recruitingChangsha, Hunan, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Extensive-stage Small-cell Lung CancerExtensive-stage Small Cell Lung Cancer (ES-SCLC)Extensive Stage Lung Small Cell Cancer+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University40 enrolled5 locationsNCT07061535